Henry Schein, Inc. (NASDAQ:HSIC) has been assigned a consensus rating of “Hold” from the eighteen brokerages that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have given a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $184.64.

Several research firms have weighed in on HSIC. Jefferies Group LLC reissued a “hold” rating and issued a $177.00 target price on shares of Henry Schein in a research note on Friday, July 21st. Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $190.00 price target on the stock in a research report on Tuesday, April 25th. Stifel Nicolaus reaffirmed a “hold” rating on shares of Henry Schein in a research report on Thursday, July 6th. Barrington Research raised their price target on Henry Schein from $196.00 to $198.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 10th. Finally, Northcoast Research raised Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price target on the stock in a research report on Monday, August 7th.

Shares of Henry Schein (HSIC) opened at 170.82 on Tuesday. The firm has a market cap of $13.50 billion, a P/E ratio of 24.96 and a beta of 1.09. The firm’s 50-day moving average price is $179.14 and its 200 day moving average price is $175.79. Henry Schein has a 12-month low of $146.23 and a 12-month high of $186.99. Shares of Henry Schein are scheduled to split on the morning of Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly created shares will be payable to shareholders after the market closes on Thursday, September 14th.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.02. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The firm had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.05 billion. During the same quarter in the prior year, the firm posted $1.64 earnings per share. The company’s quarterly revenue was up 6.4% on a year-over-year basis. On average, equities analysts expect that Henry Schein will post $7.27 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece of content was first posted by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/08/22/henry-schein-inc-hsic-receives-consensus-recommendation-of-hold-from-analysts.html.

A number of large investors have recently made changes to their positions in the stock. YorkBridge Wealth Partners LLC raised its stake in shares of Henry Schein by 5.2% in the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after buying an additional 28 shares in the last quarter. Sun Life Financial INC raised its stake in shares of Henry Schein by 8,185.7% in the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock worth $106,000 after buying an additional 573 shares in the last quarter. SpiderRock Advisors LLC purchased a new stake in shares of Henry Schein during the first quarter worth about $102,000. Lee Financial Co purchased a new stake in shares of Henry Schein during the second quarter worth about $161,000. Finally, JNBA Financial Advisors purchased a new stake in shares of Henry Schein during the first quarter worth about $170,000. 90.60% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.